<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">348613</id>
  <title nil="true"/>
  <common-name>3-[4-[3-oxo-3-(3,4,5-trimethoxyphenyl)propyl]piperazin-1-yl]-1-(3,4,5-trimethoxyphenyl)propan-1-one</common-name>
  <description>3-[4-[3-oxo-3-(3,4,5-trimethoxyphenyl)propyl]piperazin-1-yl]-1-(3,4,5-trimethoxyphenyl)propan-1-one is a chemical compound with the formula C28H38N2O8. With an average molecular weight of 530.60 g/mol, 3-[4-[3-oxo-3-(3,4,5-trimethoxyphenyl)propyl]piperazin-1-yl]-1-(3,4,5-trimethoxyphenyl)propan-1-one is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>204658</pubchem-id>
  <chemical-formula>C28H38N2O8</chemical-formula>
  <weight>530.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T12:41:48Z</created-at>
  <updated-at type="dateTime">2026-08-31T12:41:48Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=CC(=CC(=C1OC)OC)C(=O)CCN2CCN(CC2)CCC(=O)C3=CC(=C(C(=C3)OC)OC)OC</moldb-smiles>
  <moldb-formula>C28H38N2O8</moldb-formula>
  <moldb-inchi>InChI=1S/C28H38N2O8/c1-33-23-15-19(16-24(34-2)27(23)37-5)21(31)7-9-29-11-13-30(14-12-29)10-8-22(32)20-17-25(35-3)28(38-6)26(18-20)36-4/h15-18H,7-14H2,1-6H3</moldb-inchi>
  <moldb-inchikey>ONSDKECRKDIVRV-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">530.2628162</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.5</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM344506</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-[4-[3-oxo-3-(3,4,5-trimethoxyphenyl)propyl]piperazin-1-yl]-1-(3,4,5-trimethoxyphenyl)propan-1-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organic oxygen compounds</superklass>
  <klass>Organooxygen compounds</klass>
  <subklass>Carbonyl compounds</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0298943</sync-id>
  <structure-inchikey>ONSDKECRKDIVRV-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>2080000000000000000000000000000000000000000040000000200000000000040000000000000000000000080000000000000000000000000000000000000000000000000000002000000000010000000000000000000000000001000000004000000050000000000002010000000000000000000000000000004000000000000000000000400000000000000000000000000000000000000000000000000000000008400000000000000010000000a000000000000080000408000000010000000000000000000000040000000000000000000000010000000000000000000040000800000400000001000020000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKAAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:46:55Z</structure-indexed-at>
</compound>
